Stock Spotlight Archives - Page 17 of 348

FridaySep 15, 2023 1:01 pm

QualityStocksNewsBreaks – Why Renovaro BioSciences Inc. (NASDAQ: RENB) Is ‘One to Watch’

Renovaro BioSciences (NASDAQ: RENB), (formerly Enochian BioSciences Inc.), is an advanced, pre-clinical biotechnology firm in cell, gene and immunotherapy. “Renovaro aims to unlock potentially long-term or life-long cancer remission in some of the deadliest cancers, as well as to potentially treat or cure serious infectious diseases… The oncology platform is now at the forefront of Renovaro’s development activities. While Renovaro’s current efforts focus primarily on pancreatic cancer, it plans to include other solid tumors with short life-expectancy in the first in human phase I/IIa studies that are on track to start by mid-2024,” reads a recent article. “Renovaro’s proprietary, novel…

FridaySep 15, 2023 12:57 pm

QualityStocksNewsBreaks – Electronic Servitor Publication Network Inc. (XESP) Is Driving the ‘Future of Marketing’

Electronic Servitor Publication Network (OTC: XESP), a technology-oriented digital engagement and activation company, is pioneering the next step in the evolution of digital marketing with its Digital Engagement Engine(TM). “‘Our Digital Engagement Engine isn’t just another marketing tool. It’s a way to develop real connections with your target market. And it’s the future of marketing,’ explains the company. The Digital Engagement Engine is built on a robust stack of cutting-edge data analysis tools, smart technologies and microservices, which, combined, enable it to identify the narrowest of niches within a company’s target market, create content that meets customers’ exact needs, and…

FridaySep 15, 2023 12:26 pm

QualityStocksNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Looks Forward to Acclaim-3 Trial on Heels of Receipt of FDA FTD and ODD Designations

Genprex (NASDAQ: GNPX) is a clinical-stage gene therapy company focused on developing life-changing treatments for patients with cancer and diabetes. The company recently announced that the United States Food and Drug Administration (“FDA”) had granted Orphan Drug Designation (“ODD”) to its lead drug candidate, REQORSA(R) Immunogene Therapy (quratusugene ozeplasmid), for the treatment of small cell lung cancer (“SCLC”). The receipt of the ODD followed the FDA’s granting of Fast Track Designation (“FTD”) for REQORSA Immunogene Therapy in combination with Tecentriq in patients with ES-SCLC who did not develop tumor progression after receiving Tecentriq and chemotherapy as initial standard treatment. “With…

FridaySep 15, 2023 12:19 pm

QualityStocksNewsBreaks – Fintech Ecosystem Development Corp. (NASDAQ: FEXD) Tapping Emerging Technologies to Address Unmet Mobile Money Needs

Fintech Ecosystem Development Corp. (NASDAQ: FEXD) is working to develop a global financial technology ecosystem. “The company is keen on addressing unmet mobile money needs in developing and industrialized markets and making mobile transactions easier and more affordable. To turn its vision into a reality, FEXD is adopting emerging technologies like artificial intelligence (‘AI’),” a recent article reads. “Given the role AI has historically played in helping companies detect, measure and manage risk, it is still being called upon to deal with financial crime and cyber threats and detect fraud. In addition, and alongside these crucial applications of the technology,…

FridaySep 15, 2023 12:10 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Optimistic Berubicin May Provide Much-Needed Benefit for GBM Patients

CNS Pharmaceuticals (NASDAQ: CNSP), a clinical-stage biotechnology company specializing in the development of novel treatments with a focus on brain cancer, glioblastoma (“GBM”) and neuro-oncology, recently presented updated safety results from its potentially pivotal clinical study on GBM treatment through its lead drug candidate, Berubicin. “Most notably, this novel anthracycline demonstrated its capability to be a safe and innovative potential treatment option for GBM, having shown aspects integral to effective therapy for the disease… So far, 151 patients have been enrolled in the clinical study, with 105 set on Berubicin while the remaining 46 will be on Lomustine. This marks…

ThursdaySep 14, 2023 3:45 pm

QualityStocksNewsBreaks – First Tellurium Corp. (CSE: FTEL) (OTC: FSTTF) in Unique ‘Only Ones in Town’ Position

First Tellurium (CSE: FTEL) (OTC: FSTTF) president and CEO Tyron Docherty was recently featured as a guest on the Bell2Bell podcast, where he talked about the company and its key position in the growing tellurium space. “First Tellurium has a wonderful, high-grade gold and silver property in Canada, but it comes with this unique mineral, tellurium, which is listed by both the United States and Canadian governments as critical,” a recent article quotes Docherty as saying. “Tellurium has come into the fore over the last couple of decades because it is used in solar panels by U.S. corporation First Solar,…

FridaySep 08, 2023 12:21 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) ‘Strategically Important’ Patent Grants Protection in One of World’s Leading Oral Nicotine Markets

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently celebrated the receipt of U.S. patent #11,700,875, titled “Compositions and Methods For Sublingual Delivery of Nicotine.” The patent covers various forms and sources of nicotine, including nicotine benzoate, nicotine polacrilex, nicotine citrate, nicotine detartrate, and many others, for use in sublingual delivery formats like oral pouches. “The new U.S. patent is remarkable and ‘strategically important’ in many ways. First, it is the company’s 35th overall granted patent worldwide and the 13th granted in the United States. Second, a total of 30 claims were awarded within this patent,…

FridaySep 08, 2023 11:46 am

QualityStocksNewsBreaks – Eloro Resources Ltd.’s (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM) Recent Models Suggest Potential Access to High-Grade Deposit

Eloro Resources (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM), an exploration and mining company, is now embarked on the process of finalizing the release of its initial mineral resource estimate (“MRE”) report, which will seek to provide the market with further granularity as to the Iska Iska property’s viability as a commercial mining operation going forward. “Previously exploited by artisanal miners in the early 1960s, repeated surveys of Eloro’s Iska Iska and Mina Casiterita properties – the latter situated to Iska Iska’s immediate southwest, have outlined the appearance of an extensive, near surface, magnetic intrusive body spread across the two sites.…

FridaySep 08, 2023 11:25 am

QualityStocksNewsBreaks – GEMXX Corp. (GEMZ) Eyes Promising Start to Expected ‘Highly Lucrative’ First Year of Gold Mining

GEMXX (OTC: GEMZ), a mine-to-market global jewelry producer, is ramping up its capacity for gold ore processing at one of its Canadian assets, enthusiastic over the better-than-expected amount of ore produced from stockpiled surface material. “GEMXX’s Snow Creek Mine property in British Columbia completed site preparation for gold processing last year and mobilized equipment in May to begin bringing the property into full production. GEMXX reported the first production of gold from the site on Aug. 15 as ore collected from a 4,500-cubic-yard sample during construction of the facility was ‘cleaned out.’ The operation yielded 38.73 ounces of gold, amounting…

FridaySep 08, 2023 11:09 am

QualityStocksNewsBreaks – GolfLync Inc.’s User-Friendly and Feature-Rich Platform Driving Exceptional Growth, Engagement

GolfLync, the company behind the GolfLync app – a social network for matching golf games and players, is soaring due to its unique and feature-strong ability to bring together people who love golf, a sport that is experiencing a post-pandemic revival. “The app (available as a free download on the Apple App Store and the Google Play Store) is powered by an intelligent algorithm that brings golfers together based upon a balanced range of factors, including handicap, preferred playing style, and location, along with various related interests and specifications. The app readily supports everything from matching individual partners to building…

Site Search

Company Search

Category: Stock Spotlight